MacBeath Gavin 4
4 · TScan Therapeutics, Inc. · Filed Jan 20, 2022
Insider Transaction Report
Form 4
MacBeath Gavin
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-18+140,000→ 140,000 totalExercise: $4.85Exp: 2032-01-17→ Voting Common Stock (140,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option vest over 4 years of service following January 18, 2022, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter.